Bavarian Nordic Hones Infectious Disease Focus by Dropping Cancer Vaccine R&D
Bavarian Nordic will concentrate on its portfolio and pipeline of infectious diseases vaccines, including top seller Jynneos, approved for mpox and smallpox. The company only had one clinical-stage cancer vaccine program.